Eliana Marino Moreno

Personal profile

Biography

Dr Marino’s research program has fundamentally shifted our understanding of the role diet, gut microbiota, and the immune system in the development of T1D, spurring new research directions worldwide and bringing diet-based therapeutic options one step closer by advancing this basic research to clinical trials. Eliana has secure >$2 million research funding including the prestigious Type 1 Millennium Award from the Diabetes Australia Research Trust and the USA Juvenile Diabetes Research Foundation postdoctoral (JDRF) fellowship. Dr Marino has disseminated her work to the community and public through forums to general practitioners, clinicians, philanthropic partners, industry and educational events, such as the Melbourne Museum exhibition the “Gut Feelings”

Research interests

Immunology, inflammation and autoimmunity, specifically in B cell migration, cross-presentation of auto-antigens and Treg cells.

Dr. Marino's current research is at the cutting edge of the field and her lab is one of the leading groups worldwide studying the role of diet and microbiota on the course of autoimmune diabetes and related complications such as kidney disease and obesity.

External positions

Adjunct Fellow, Charles Perkins Centre

14 Nov 2014 → 21 Dec 2021

Research area keywords

Diabetes
Diet and nutrition
Immunology
Inflammation
Microbiome
mucosal Immunology
Autoimmunity
Type 1 diabetes

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2020

1 Not started
2 Active
4 Finished

The use of dietary supplements which release high levels of gut metabolites to lower blood pressure: a phase IIa clinical trial

Coelho Marques, F., Kaye, D., Mackay, C. & Marino Moreno, E.

Heart Foundation

1/01/19 → 31/12/19

Project: Research

Specialized dietary intervention in human type 1 diabetes

Marino Moreno, E., Bell, K., Saad, S. & Hamilton-Williams, E. E.

21/06/18 → 20/03/20

Project: Research

Gut Microbiota Dysbiosis in Diet-induced Obesity and Insulin Resistance and the Prebiotic Potential of Geraniin-enriched Extract

Devi, U., Marino Moreno, E., Chua, K. H. & Abdul Kadir, K.

Project: Research

Dietary Manipulation of Gut Microbial Metabolites Mitigate Type 1 Diabetes

Marino Moreno, E.

Juvenile Diabetes Research Foundation (JDRF US)

1/06/16 → 31/05/18

Project: Research

Gut microbiota and SCFAS play a key role in the pathogenesis of type 1 diabetes

Marino Moreno, E.

Diabetes Australia

1/01/14 → 31/12/15

Project: Research

Research Output 2003 2019

17 Article
6 Review Article
1 Chapter (Book)
1 Comment / Debate
1 More
- 1 Scientific Review

1 Citation (Scopus)

Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia

Hu, M., Eviston, D., Hsu, P., Mariño, E., Chidgey, A., Santner-Nanan, B., Wong, K., Richards, J. L., Yap, Y. A., Collier, F., Quinton, A., Joung, S., Peek, M., Benzie, R., Macia, L., Wilson, D., Ponsonby, A. L., Tang, M. L. K., O’Hely, M., Daly, N. L. & 5 others, Mackay, C. R., Dahlstrom, J. E., The BIS Investigator Group, Vuillermin, P. & Nanan, R., 10 Jul 2019, In : Nature Communications. 10, 1, 13 p., 3031.

Research output: Contribution to journal › Article › Research › peer-review

Open Access

File

Dietary scfas, il-22, and gfap: The three musketeers in the gut–neuro–immune network in type 1 diabetes

Jayasimhan, A. & Mariño, E., Oct 2019, In : Frontiers in Immunology. 10, 8 p., 2429.

Research output: Contribution to journal › Review Article › Research › peer-review

Open Access

File

Dietary Short Chain Fatty Acids: How the gut microbiota fight against autoimmune and inflammatory diseases

McLeod, K. H., Richards, J. L., Yap, Y. A. & Marino, E., 2019, Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Watson, R. & Preedy, V. (eds.). 2nd ed. Academic Press, p. 139-159 21 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms

Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., Ferreira, C. M., Parmigiani, R. B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Mariño, E., Robert, R., Mackay, C. R. & Camara, N. O. S., Nov 2019, (Accepted/In press) In : FASEB Journal. 33, 15 p.

Research output: Contribution to journal › Article › Research › peer-review